In 2020 Caprica began their mission to design and build a proof-of-concept cleanroom facility, regenerating an existing agricultural site, to facilitate the highest degree of control and security of product and process.
Taking lessons learned and systems developed in North America and Europe alike, they completed their phase 1 build and commissioning in Q1 2022. Since the granting of their high-THC licence, they have developed and evolved their working practices, documentation and Quality Management System to tune efficacy, efficiency, consistency and quality.
They are on track to achieve Jersey, Channel Islands Medicinal Manufacturing (MHRA aligned Specials Manufacturing) license in Q4/24.
